These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
479 related articles for article (PubMed ID: 8806796)
1. Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats. Kawai K; Kobayashi Y; Shiratori M; Sobue G; Tamatani T; Miyasaka M; Yoshikai Y Cell Immunol; 1996 Aug; 171(2):262-8. PubMed ID: 8806796 [TBL] [Abstract][Full Text] [Related]
2. Antibodies against leukocyte function-associated antigen-1 and against intercellular adhesion molecule-1 together suppress the progression of experimental allergic encephalomyelitis. Kobayashi Y; Kawai K; Honda H; Tomida S; Niimi N; Tamatani T; Miyasaka M; Yoshikai Y Cell Immunol; 1995 Sep; 164(2):295-305. PubMed ID: 7544693 [TBL] [Abstract][Full Text] [Related]
3. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2. Jung S; Toyka K; Hartung HP Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758 [TBL] [Abstract][Full Text] [Related]
4. Short term treatment with soluble neuroantigen and anti-CD11a (LFA-1) protects rats against autoimmune encephalomyelitis: treatment abrogates autoimmune disease but not autoimmunity. Willenborg DO; Staykova MA; Miyasaka M J Immunol; 1996 Sep; 157(5):1973-80. PubMed ID: 8757317 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells. Hilliard BA; Kamoun M; Ventura E; Rostami A Exp Mol Pathol; 2000 Feb; 68(1):29-37. PubMed ID: 10640452 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Archelos JJ; Jung S; Mäurer M; Schmied M; Lassmann H; Tamatani T; Miyasaka M; Toyka KV; Hartung HP Ann Neurol; 1993 Aug; 34(2):145-54. PubMed ID: 7687838 [TBL] [Abstract][Full Text] [Related]
7. Experimental allergic encephalomyelitis (EAE): role of B cell and T cell epitopes in the development of EAE in Lewis rats. Hashim GA; Day ED; Carvalho E; Abdelaal A J Neurosci Res; 1987; 17(4):375-83. PubMed ID: 2442406 [TBL] [Abstract][Full Text] [Related]
8. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats. Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538 [TBL] [Abstract][Full Text] [Related]
9. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction. Hinrichs DJ; Roberts CM; Waxman FJ J Immunol; 1981 May; 126(5):1857-62. PubMed ID: 6163820 [TBL] [Abstract][Full Text] [Related]
10. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis. Gold DP; Schroder K; Powell HC; Kelly CJ Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811 [TBL] [Abstract][Full Text] [Related]
11. Suppression of experimental uveitis with monoclonal antibodies to ICAM-1 and LFA-1. Uchio E; Kijima M; Tanaka S; Ohno S Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2626-31. PubMed ID: 7909311 [TBL] [Abstract][Full Text] [Related]
12. The role of serum factors in the suppression of experimental allergic encephalomyelitis: evidence for immunoregulation by antibody to the encephalitogenic peptide. MacPhee IA; Day MJ; Mason DW Immunology; 1990 Aug; 70(4):527-34. PubMed ID: 1697565 [TBL] [Abstract][Full Text] [Related]
13. Immunomodulation of experimental autoimmune encephalomyelitis by staphylococcal enterotoxin D. Matsumoto Y; Fujiwara M Cell Immunol; 1993 Jul; 149(2):268-78. PubMed ID: 7687198 [TBL] [Abstract][Full Text] [Related]
14. Experimental allergic encephalomyelitis supernatant transfer activity (EAE-STA) in Lewis rats:immunobiologic and initial biochemical properties. Whitacre CC; Paterson PY J Immunol; 1980 Apr; 124(4):1784-8. PubMed ID: 6965962 [TBL] [Abstract][Full Text] [Related]
15. Chronic permeability of the central nervous system to mononuclear cells in experimental allergic encephalomyelitis in the Lewis rat. Stohl W; Gonatas NK J Immunol; 1978 Sep; 121(3):844-50. PubMed ID: 308523 [TBL] [Abstract][Full Text] [Related]
16. Propentofylline and iloprost suppress the production of TNF-alpha by macrophages but fail to ameliorate experimental autoimmune encephalomyelitis in Lewis rats. Jung S; Donhauser T; Toyka KV; Hartung HP J Autoimmun; 1997 Dec; 10(6):519-29. PubMed ID: 9451591 [TBL] [Abstract][Full Text] [Related]
17. Anti-T cell monoclonal antibodies in vivo. II. Modulation of acute and chronic experimental allergic encephalomyelitis (EAE) in guinea pigs. Sobel RA; Blanchette BW; Russo MA; Williams AM; Colvin RB J Immunol; 1987 Apr; 138(8):2507-13. PubMed ID: 3494072 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of the rat central nervous system during experimental allergic encephalomyelitis, with special reference to Ia-positive cells with dendritic morphology. Matsumoto Y; Hara N; Tanaka R; Fujiwara M J Immunol; 1986 May; 136(10):3668-76. PubMed ID: 3084638 [TBL] [Abstract][Full Text] [Related]
19. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4. Ramírez F; Mason D Eur J Immunol; 2000 Mar; 30(3):747-58. PubMed ID: 10741389 [TBL] [Abstract][Full Text] [Related]
20. OX-40 antibody enhances for autoantigen specific V beta 8.2+ T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis. Weinberg AD; Lemon M; Jones AJ; Vainiene M; Celnik B; Buenafe AC; Culbertson N; Bakke A; Vandenbark AA; Offner H J Neurosci Res; 1996 Jan; 43(1):42-9. PubMed ID: 8838572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]